Search

for
Search:

GlossaryVincristine

chemotherapy drug that inhibits cancer cell division

Vincristine is a chemotherapy drug used to treat various types of cancer, including leukemia and lymphoma. It works by inhibiting the growth of cancer cells by interfering with their ability to divide. However, one of its side effects can be hair loss (alopecia), as it also affects rapidly dividing cells in hair follicles.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 230 results

research Peptichemio: A New Oncolytic Drug in Combination with Vincristine and Prednisolone in the Treatment of Non-Hodgkin Lymphomas

8 citations , January 1977 in “Acta Haematologica”

The treatment was effective for advanced non-Hodgkin's lymphomas.

research Efficacy of Combination Chemotherapy With Mitoxantrone, Vincristine, Prednisolone (MVP) for Recurrence of Breast Cancer

January 1995 in “PubMed”

MVP treatment is effective and safe for recurrent breast cancer.

research Prolonged Remissions of Metastatic Breast Cancer Achieved With a Six-Drug Regimen of Relatively Low Toxicity

6 citations , June 1983 in “Cancer”

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

research Scalp Tourniquets for Chemotherapy-Induced Alopecia

3 citations , May 1980 in “American Journal of Nursing”

Scalp tourniquets did not significantly prevent hair loss from chemotherapy.

research Conceptual Basis for Use of Chemotherapeutic Agents and Their Pharmacology

3 citations , February 1976 in “Pediatric Clinics of North America”

The conclusion is that effective cancer treatment often requires a combination of therapies, but must be carefully managed due to serious side effects and the risk of immunosuppression.

View more "vincristine" in research →

Community Join

0 / 0 results

— no results